Variant report
Variant | esv2468772 |
---|---|
Chromosome Location | chr3:88459429-88460904 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533811237 | chr3:88459437-88459438 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558541354 | chr3:88459457-88459458 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79657494 | chr3:88459499-88459500 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537599540 | chr3:88459557-88459558 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181779513 | chr3:88459570-88459571 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557478850 | chr3:88459594-88459595 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114617019 | chr3:88459595-88459596 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543080366 | chr3:88459611-88459612 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561246336 | chr3:88459616-88459617 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573246927 | chr3:88459617-88459618 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113637221 | chr3:88459649-88459650 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186366249 | chr3:88459670-88459671 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532742538 | chr3:88459723-88459724 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138824993 | chr3:88459726-88459727 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs578105568 | chr3:88459758-88459759 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562282057 | chr3:88459809-88459810 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529724408 | chr3:88459840-88459841 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142004303 | chr3:88459898-88459899 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1379699 | chr3:88459954-88459955 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533517240 | chr3:88459959-88459960 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35491794 | chr3:88459973-88459974 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561237816 | chr3:88460017-88460018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190325751 | chr3:88460020-88460021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560830454 | chr3:88460027-88460028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1563669 | chr3:88460030-88460031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs183485403 | chr3:88460032-88460033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188213321 | chr3:88460072-88460073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191361250 | chr3:88460079-88460080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575838138 | chr3:88460119-88460120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114357839 | chr3:88460177-88460178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146335397 | chr3:88460179-88460180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573283614 | chr3:88460224-88460225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182736629 | chr3:88460283-88460284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35505048 | chr3:88460288-88460289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531947296 | chr3:88460320-88460321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375077572 | chr3:88460335-88460336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544823370 | chr3:88460350-88460351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550529934 | chr3:88460351-88460352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562719268 | chr3:88460414-88460415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs367694919 | chr3:88460440-88460441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186920168 | chr3:88460455-88460456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34247351 | chr3:88460493-88460494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28628096 | chr3:88460494-88460495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527330482 | chr3:88460497-88460498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533598677 | chr3:88460501-88460502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555320029 | chr3:88460504-88460505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551878702 | chr3:88460521-88460522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12486842 | chr3:88460525-88460526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs59764316 | chr3:88460528-88460529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6770586 | chr3:88460529-88460530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Lung cancer | 19547694 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:88459000-88460000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr3:88459000-88460000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr3:88459200-88459600 | Flanking Active TSS | Primary T cells from cord blood | blood |
4 | chr3:88459200-88460200 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr3:88459600-88460000 | Active TSS | Primary T cells from cord blood | blood |
6 | chr3:88459800-88460200 | Enhancers | Primary T helper cells fromperipheralblood | blood |
7 | chr3:88460000-88460800 | Enhancers | Primary T cells from cord blood | blood |
8 | chr3:88460800-88461200 | Weak transcription | Primary T cells from cord blood | blood |